MyoKardia Inc (MYOK)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: MYOK Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2020-07-07 2020-07-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,224 -14.4%
94.22
303,767 USD 		3,224 -14.4% 94.22 303,767 USD
2020-07-07 2020-07-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,776 -7.4%
93.55
166,142 USD 		1,776 -7.4% 93.55 166,142 USD
2020-07-01 2020-06-30 S Sale

CRANSTON MARY B

Non-Executive Director
21,329 -100.0%
96.59
2,060,179 USD 		21,329 -100.0% 96.59 2,060,179 USD
2020-07-01 2020-06-30 S Sale

CRANSTON MARY B

Non-Executive Director
300 -1.4%
97.25
29,176 USD 		300 -1.4% 97.25 29,176 USD
2020-07-01 2020-06-29 S Sale

CRANSTON MARY B

Non-Executive Director
371 -100.0%
98.68
36,611 USD 		371 -100.0% 98.68 36,611 USD
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
319 -1.3%
104.64
33,382 USD 		319 -1.3% 104.64 33,382 USD
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,885 -7.2%
103.77
195,609 USD 		1,885 -7.2% 103.77 195,609 USD
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,396 -5.0%
102.78
143,481 USD 		1,396 -5.0% 102.78 143,481 USD
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
800 -2.8%
101.72
81,378 USD 		800 -2.8% 101.72 81,378 USD
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -2.1%
100.60
60,357 USD 		600 -2.1% 100.60 60,357 USD
2020-05-20 2020-05-18 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
10,000 -25.6%
125.00
1,250,000 USD 		10,000 -25.6% 125.00 1,250,000 USD
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -1.5%
103.33
61,998 USD 		600 -1.5% 103.33 61,998 USD
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,519 -8.1%
102.56
360,921 USD 		3,519 -8.1% 102.56 360,921 USD
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
18,581 -30.1%
101.90
1,893,486 USD 		18,581 -30.1% 101.90 1,893,486 USD
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,700 -2.7%
100.51
170,860 USD 		1,700 -2.7% 100.51 170,860 USD
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.9%
98.69
59,213 USD 		600 -0.9% 98.69 59,213 USD
2020-05-06 2020-05-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
305 -0.4%
60.15
18,346 USD 		305 -0.4% 60.15 18,346 USD
2020-05-06 2020-05-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,909 -3.8%
59.10
171,916 USD 		2,909 -3.8% 59.10 171,916 USD
2020-05-06 2020-05-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
400 -0.5%
58.05
23,218 USD 		400 -0.5% 58.05 23,218 USD
2020-05-06 2020-05-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,386 -1.8%
56.93
78,907 USD 		1,386 -1.8% 56.93 78,907 USD
2020-04-20 2020-04-16 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.3%
55.00
55,000 USD 		1,000 -1.3% 55.00 55,000 USD
2020-04-10 2020-04-08 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,500 -1.9%
50.00
75,000 USD 		1,500 -1.9% 50.00 75,000 USD
2020-04-07 2020-04-06 S Sale

Harris Taylor C.

Chief Financial Officer

Officer
1,305 -14.9%
46.99
61,322 USD 		1,305 -14.9% 46.99 61,322 USD
2020-04-06 2020-04-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.8%
46.23
27,736 USD 		600 -0.8% 46.23 27,736 USD
2020-04-06 2020-04-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
300 -0.4%
45.35
13,605 USD 		300 -0.4% 45.35 13,605 USD
2020-04-06 2020-04-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.2%
44.47
44,469 USD 		1,000 -1.2% 44.47 44,469 USD
2020-04-06 2020-04-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.7%
43.51
26,107 USD 		600 -0.7% 43.51 26,107 USD
2020-03-04 2020-03-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
22 -0.0%
65.97
1,451 USD 		22 -0.0% 65.97 1,451 USD
2020-03-04 2020-03-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,800 -2.2%
65.19
117,346 USD 		1,800 -2.2% 65.19 117,346 USD
2020-03-04 2020-03-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,070 -2.4%
64.35
133,203 USD 		2,070 -2.4% 64.35 133,203 USD
2020-03-04 2020-03-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,108 -1.3%
63.40
70,246 USD 		1,108 -1.3% 63.40 70,246 USD
2020-02-05 2020-02-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.1%
69.74
69,744 USD 		1,000 -1.1% 69.74 69,744 USD
2020-02-05 2020-02-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
4,000 -4.4%
69.27
277,077 USD 		4,000 -4.4% 69.27 277,077 USD
2020-02-03 2020-02-01 S Sale

Fairey William

See Remarks
2,899 -35.7%
68.04
197,248 USD 		2,899 -35.7% 68.04 197,248 USD
2020-01-14 2020-01-14 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
5,000 -5.2%
75.39
376,965 USD 		5,000 -5.2% 75.39 376,965 USD
2020-01-07 2020-01-06 S Sale

Harris Taylor C.

Chief Financial Officer
1,683 -25.2%
68.45
115,203 USD 		1,683 -25.2% 68.45 115,203 USD
2020-01-07 2020-01-06 S Sale

LADD CYNTHIA J

General Counsel
1,849 -39.3%
68.45
126,566 USD 		1,849 -39.3% 68.45 126,566 USD
2020-01-07 2020-01-06 S Sale

McDowell Robert Scott

Chief Scientific Officer
2,650 -33.0%
68.45
181,395 USD 		2,650 -33.0% 68.45 181,395 USD
2020-01-07 2020-01-06 S Sale

Bauer Jake

Chief Business Officer
2,466 -4.1%
68.45
168,800 USD 		2,466 -4.1% 68.45 168,800 USD
2020-01-07 2020-01-06 S Sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
12,687 -11.6%
68.45
868,439 USD 		12,687 -11.6% 68.45 868,439 USD
2020-01-03 2020-01-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,084 -1.9%
72.27
150,617 USD 		2,084 -1.9% 72.27 150,617 USD
2020-01-03 2020-01-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,616 -2.3%
71.59
187,287 USD 		2,616 -2.3% 71.59 187,287 USD
2020-01-03 2020-01-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
300 -0.3%
70.35
21,105 USD 		300 -0.3% 70.35 21,105 USD
2019-12-23 2019-12-20 PS Planned sale

Bauer Jake

Chief Business Officer

Officer
18,916 -30.3%
70.07
1,325,421 USD 		18,916 -30.3% 70.07 1,325,421 USD
2019-12-04 2019-12-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
4,350 -4.8%
65.14
283,342 USD 		4,350 -4.8% 65.14 283,342 USD
2019-12-04 2019-12-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
650 -0.7%
64.24
41,755 USD 		650 -0.7% 64.24 41,755 USD
2019-12-02 2019-11-29 PS Planned sale

Bauer Jake

Chief Business Officer

Officer
800 -1.7%
66.32
53,056 USD 		800 -1.7% 66.32 53,056 USD
2019-12-02 2019-11-29 PS Planned sale

Bauer Jake

Chief Business Officer

Officer
7,336 -13.8%
65.52
480,655 USD 		7,336 -13.8% 65.52 480,655 USD
2019-12-02 2019-11-27 PS Planned sale

Bauer Jake

Chief Business Officer

Officer
13,096 -19.8%
65.13
852,977 USD 		13,096 -19.8% 65.13 852,977 USD
2019-11-06 2019-11-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
5,000 -5.2%
59.07
295,365 USD 		5,000 -5.2% 59.07 295,365 USD
2019-10-04 2019-10-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
55.00
55,000 USD 		1,000 -1.0% 55.00 55,000 USD
2019-10-04 2019-10-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
758 -0.8%
53.10
40,248 USD 		758 -0.8% 53.10 40,248 USD
2019-10-04 2019-10-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,542 -2.5%
52.29
132,933 USD 		2,542 -2.5% 52.29 132,933 USD
2019-10-04 2019-10-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
700 -0.7%
51.33
35,930 USD 		700 -0.7% 51.33 35,930 USD
2019-09-24 2019-09-23 PS Planned sale

Lee June

EVP, Chief Development Officer
4,161 -50.0%
61.09
254,191 USD 		4,161 -50.0% 61.09 254,191 USD
2019-09-24 2019-09-23 PS Planned sale

Lee June

EVP, Chief Development Officer
800 -8.8%
59.95
47,960 USD 		800 -8.8% 59.95 47,960 USD
2019-09-24 2019-09-23 PS Planned sale

Lee June

EVP, Chief Development Officer
4,161 -31.3%
58.97
245,389 USD 		4,161 -31.3% 58.97 245,389 USD
2019-09-24 2019-09-23 PS Planned sale

Lee June

EVP, Chief Development Officer
3,929 -22.8%
58.33
229,184 USD 		3,929 -22.8% 58.33 229,184 USD
2019-09-24 2019-09-20 PS Planned sale

Bauer Jake

Chief Business Officer
19,700 -23.0%
60.09
1,183,777 USD 		19,700 -23.0% 60.09 1,183,777 USD
2019-09-20 2019-09-19 PS Planned sale

Lee June

EVP, Chief Development Officer
5,435 -54.3%
57.08
310,254 USD 		5,435 -54.3% 57.08 310,254 USD
2019-09-12 2019-09-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
55.00
55,000 USD 		1,000 -1.0% 55.00 55,000 USD
2019-09-05 2019-09-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,100 -1.1%
54.09
59,500 USD 		1,100 -1.1% 54.09 59,500 USD
2019-09-05 2019-09-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
52.75
52,750 USD 		1,000 -1.0% 52.75 52,750 USD
2019-09-05 2019-09-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,900 -1.8%
50.70
96,335 USD 		1,900 -1.8% 50.70 96,335 USD
2019-08-12 2019-08-09 PS Planned sale

Lee June

EVP, Chief Development Officer

Officer
4,565 -49.9%
57.00
260,219 USD 		4,565 -49.9% 57.00 260,219 USD
2019-08-09 2019-08-08 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -0.9%
55.09
55,090 USD 		1,000 -0.9% 55.09 55,090 USD
2019-08-05 2019-08-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
200 -0.2%
53.82
10,764 USD 		200 -0.2% 53.82 10,764 USD
2019-08-05 2019-08-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,800 -3.4%
53.20
202,171 USD 		3,800 -3.4% 53.20 202,171 USD
2019-07-23 2019-07-22 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -0.9%
55.00
55,000 USD 		1,000 -0.9% 55.00 55,000 USD
2019-07-08 2019-07-05 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,450 -2.1%
50.10
122,752 USD 		2,450 -2.1% 50.10 122,752 USD
2019-07-08 2019-07-05 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,550 -1.3%
49.13
76,151 USD 		1,550 -1.3% 49.13 76,151 USD
2019-04-09 2019-04-05 S Sale

Harris Taylor C.

Chief Financial Officer
1,324 -35.3%
53.30
70,569 USD 		1,324 -35.3% 53.30 70,569 USD
2019-02-15 2019-02-13 S Sale

Sanofi

Large shareholder
4,168,899 -100.0%
37.66
157,000,736 USD 		4,168,899 -100.0% 37.66 157,000,736 USD
2019-01-11 2019-01-07 S Sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,770 -3.5%
44.11
122,197 USD 		2,770 -3.5% 44.11 122,197 USD
2019-01-08 2019-01-04 B Purchase

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,600 +1.8%
39.87
63,796 USD 		1,600 +1.8% 39.87 63,796 USD